Company intelligence / Profile preview
Labiana
- Ownership
- Private
- Employees
- ~464
- Development stage
- Commercial
Overview
Labiana operates as a fully integrated pharmaceutical group with over six decades of experience, specializing in the development, manufacturing, and commercialization of medicines for both human and animal health. Its lead branded product for humans is fosfomycin trometamol ("Fosfomicina Labiana"), while its animal health division markets over fifty proprietary products globally. The company also provides comprehensive contract development and manufacturing services to third parties across sterile/nonsterile forms including biologics.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Small moleculeBiologicRecombinant proteinSterile injectable forms
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Labiana.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Labiana.